The role of NFκB signaling in GBM recurrence is consistent with its proposed role in GBM initiating cell (GICs) biology and proliferation, which is thought to be due to NFκB-dependent regulation of cancer stem cell genes, including CD44 and cyclin D1 (reviewed in [58]). This evidence concerns the gene CCND1 and glioblastoma.